Literature DB >> 9739061

MHC haplotype-dependent regulation of MOG-induced EAE in rats.

R Weissert1, E Wallström, M K Storch, A Stefferl, J Lorentzen, H Lassmann, C Linington, T Olsson.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) induced in the rat by active immunization with myelin-oligodendrocyte-glycoprotein (MOG) is mediated by synergy between MOG-specific T cells and demyelinating MOG-specific antibody responses. The resulting disease is chronic and displays demyelinating central nervous system (CNS) pathology that closely resembles multiple sclerosis. We analyzed major histocompatibility complex (MHC) haplotype influences on this disease. The MHC haplotype does not exert an all-or-none effect on disease susceptibility. Rather, it determines the degree of disease susceptibility, recruitment of MOG-specific immunocompetent cells, clinical course, and CNS pathology in a hierarchical and allele-specific manner. Major haplotype-specific effects on MOG-EAE map to the MHC class II gene region, but this effect is modified by other MHC genes. In addition, non-MHC genes directly influence both disease and T cell functions, such as the secretion of IFN-gamma. Thus, in MOG-EAE, allelic MHC class II effects are graded, strongly modified by other MHC genes, and overcome by effects of non-MHC genes and environment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9739061      PMCID: PMC509110          DOI: 10.1172/JCI3022

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

Review 1.  Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes.

Authors:  A Lanzavecchia
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

2.  Distribution of plasma cells secreting antibodies against nervous tissue antigens during experimental allergic encephalomyelitis enumerated by a nitrocellulose immunospot assay.

Authors:  A C Zachau; K Strigård; S Baig; B Höjeberg; T Olsson
Journal:  J Neurol Sci       Date:  1989-07       Impact factor: 3.181

3.  Influence of the major histocompatibility complex on positive thymic selection of V beta 17a+ T cells.

Authors:  M A Blackman; P Marrack; J Kappler
Journal:  Science       Date:  1989-04-14       Impact factor: 47.728

Review 4.  HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation.

Authors:  O Olerup; J Hillert
Journal:  Tissue Antigens       Date:  1991-07

5.  The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat.

Authors:  M Adelmann; J Wood; I Benzel; P Fiori; H Lassmann; J M Matthieu; M V Gardinier; K Dornmair; C Linington
Journal:  J Neuroimmunol       Date:  1995-12       Impact factor: 3.478

6.  Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant.

Authors:  J C Lorentzen; S Issazadeh; M Storch; M I Mustafa; H Lassman; C Linington; L Klareskog; T Olsson
Journal:  J Neuroimmunol       Date:  1995-12-31       Impact factor: 3.478

7.  The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis.

Authors:  K Vass; H Lassmann; H Wekerle; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

8.  Experimental allergic encephalomyelitis induced by proteolipid apoprotein in Lewis rats.

Authors:  T Yamamura; T Namikawa; M Endoh; T Kunishita; T Tabira
Journal:  J Neuroimmunol       Date:  1986-08       Impact factor: 3.478

9.  Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects.

Authors:  M P Happ; P Wettstein; B Dietzschold; E Heber-Katz
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

10.  Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions.

Authors:  H Lassmann; C Brunner; M Bradl; C Linington
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

View more
  56 in total

1.  The arthritogenic adjuvant squalene does not accumulate in joints, but gives rise to pathogenic cells in both draining and non-draining lymph nodes.

Authors:  B C Holm; L Svelander; A Bucht; J C Lorentzen
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

2.  Skewed autoantibody reactivity to the extracellular domain of myelin oligodendrocyte glycoprotein in multiple sclerosis.

Authors:  Maria V Tejada-Simon; Jian Hong; Victor M Rivera; Jingwu Z Zhang
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

3.  Disruption of prion protein-HOP engagement impairs glioblastoma growth and cognitive decline and improves overall survival.

Authors:  M H Lopes; T G Santos; B R Rodrigues; N Queiroz-Hazarbassanov; I W Cunha; A P Wasilewska-Sampaio; B Costa-Silva; F A Marchi; L F Bleggi-Torres; P I Sanematsu; S H Suzuki; S M Oba-Shinjo; S K N Marie; E Toulmin; A F Hill; V R Martins
Journal:  Oncogene       Date:  2014-08-25       Impact factor: 9.867

4.  Considerable haplotypic diversity in the RT1-CE class I gene region of the rat major histocompatibility complex.

Authors:  Christian Roos; Lutz Walter
Journal:  Immunogenetics       Date:  2004-12-01       Impact factor: 2.846

Review 5.  Genetic determinants of risk and progression in multiple sclerosis.

Authors:  Alessandro Didonna; Jorge R Oksenberg
Journal:  Clin Chim Acta       Date:  2015-02-04       Impact factor: 3.786

6.  An informative set of SSLP markers and genomic profiles in the rat MHC, the RT1 complex.

Authors:  Yumie Takagi; Takashi Kuramoto; Birger Voigt; Toshiko Tsurumi; Satoshi Nakanishi; Tomoji Mashimo; Norio Masui; Tadao Serikawa
Journal:  Immunogenetics       Date:  2008-12-24       Impact factor: 2.846

7.  Eae19, a new locus on rat chromosome 15 regulating experimental autoimmune encephalomyelitis.

Authors:  Jian Rong Sheng; Maja Jagodic; Ingrid Dahlman; Kristina Becanovic; Rita Nohra; Monica Marta; Ellen Iacobaeus; Tomas Olsson; Erik Wallström
Journal:  Genetics       Date:  2005-02-16       Impact factor: 4.562

8.  Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.

Authors:  Hüseyin Duyar; Jörn Dengjel; Katrien L de Graaf; Karl-Heinz Wiesmüller; Stefan Stevanović; Robert Weissert
Journal:  Immunogenetics       Date:  2005-02-12       Impact factor: 2.846

9.  White matter disease: Roles of anti-MOG antibodies in demyelinating diseases.

Authors:  Tomas Olsson
Journal:  Nat Rev Neurol       Date:  2011-04-12       Impact factor: 42.937

10.  Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.

Authors:  Katarina Tengvall; Jesse Huang; Cecilia Hellström; Patrick Kammer; Martin Biström; Burcu Ayoglu; Izaura Lima Bomfim; Pernilla Stridh; Julia Butt; Nicole Brenner; Angelika Michel; Karin Lundberg; Leonid Padyukov; Ingrid E Lundberg; Elisabet Svenungsson; Ingemar Ernberg; Sigurgeir Olafsson; Alexander T Dilthey; Jan Hillert; Lars Alfredsson; Peter Sundström; Peter Nilsson; Tim Waterboer; Tomas Olsson; Ingrid Kockum
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.